Clinical Drug Experience Knowledgebase

Arthritis (Phase 3)

Arthritis, Psoriatic (Phase 3)

Arthritis, Rheumatoid (Phase 3)

Arthrogryposis (Phase 2)

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Crohn Disease (Phase 3)

Cystic Fibrosis (Phase 2)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Fibrosis (Phase 3)

Idiopathic Pulmonary Fibrosis (Phase 3)

Inflammatory Bowel Diseases (Phase 2)

Intestinal Diseases (Phase 2)

Kidney Diseases (Phase 2)

Lupus Erythematosus, Cutaneous (Phase 2)

Lupus Erythematosus, Systemic (Phase 2)

Multiple Sclerosis (Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Neoplasms (Phase 1)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Polycystic Kidney, Autosomal Dominant (Phase 2)

Polycystic Kidney Diseases (Phase 2)

Psoriasis (Phase 1)

Pulmonary Fibrosis (Phase 3)

Renal Insufficiency (Phase 1)

Scleroderma, Diffuse (Phase 2)

Scleroderma, Systemic (Phase 2)

Sclerosis (Phase 2)

Sjogren's Syndrome (Phase 2)

Spondylarthritis (Phase 2)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Syndrome (Phase 2)

Ulcer (Phase 3)